EIC Scaling Club Growth Forum 2026
We are thrilled to be attending the Growth Forum on 18 March – a day of big ideas, bold conversations, and brilliant people. Let’s connect if you’ll be there too!
Welcome to the team, Andrea Sadlonova!
We are pleased to announce that Andrea Sadlonova is joining our team as Head of clinical and regulatory affairs as of January 2026. Andrea has a PhD degree in molecular and cellular pathology from University of Alabama in Birmingham (AL, USA). She brings to our company a very valuable experience gained during her post-doctoral […]
Prestigious award!
Great news for Glycanostics! It is a great pleasure to announce that our leading scientist Jan Tkac, PhD. received a prestigious award “Rad Ľudovíta Štúra II. class”. President of Slovakia Peter Pellegrini awarded Jan for his extraordinary research results in the area of sciences and technology, especially in the field of nanobiotechnology, as well as […]
Medica 2025
This year we are exhibiting at Medica 2025 congress in Duesseldorf for the first time. Please meet us in our booth No. 15C41 in pavillion 15. We look forward to talking to you.
Welcome to the team, Ivan Durovcik!
It is our great pleasure to announce that Ivan Durovcik decided to join Glycanostics team as Chief Operating Officer in October 2025. Ivan brings more than 15 years of experience working for Novartis and Sandoz as CFO in Slovakia, Poland, Slovenia, as well as cluster CFO for Eastern Europe. We are looking forward to creating […]
Eva Kovacova joins Glycanostics as CEO as of January 2021
We are pleased to announce that Eva Kovacova joined Glycanostics as our CEO as of January 2021. Eva worked more than 18 years for some of the largest pharmaceutical companies as Director Corporate Development, as well as Finance Director. She was member of the team that secured signing of 3-arm transaction between GSK and Novartis […]
